Effects of Bu Shen Tong Luo decoction on matrix metalloproteinase-1, matrix metalloproteinase-3, tissue inhibitor of matrix metalloprotease-1 and interleukin-1beta content in the synovial fluid and serum of patients with knee osteoarthritis

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 12, Issue 28, 2008, Pages 5581-5585

  Fang, Rui ^a   Meng, Qing Cai ^a   Deng, Ying Jie ^a   Song, Gang ^a   Bai, Yu Ping ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACHYRANTHIS BIDENTATAE EXTRACT; ANGELICA PUBESCENTIS EXTRACT; ANGELICA SINENSIS EXTRACT; BU SHEN TONG LUO; CHINESE DRUG; CORNUS EXTRACT; EARTHWORM EXTRACT; EUCOMMIA ULMOIDES EXTRACT; GENTIANAE MACROPHYLLAE EXTRACT; GLYCYRRHIZA EXTRACT; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MANCHURIAN WILDGINGER EXTRACT; NATURAL PRODUCT; PLANT EXTRACT; REHMANNIA EXTRACT; SILERIS EXTRACT; STROMELYSIN; TAXILLUS EXTRACT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ACHYRANTHIS BIDENTATAE; ADULT; AGED; ANGELICA; ANGELICA PUBESCENTIS; ANGELICA SINENSIS; ARTHROSCOPY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CHINA; CHINESE HERB; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNUS; DEBRIDEMENT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EARTHWORM; ENZYME LINKED IMMUNOSORBENT ASSAY; EVENING DOSAGE; EXTRACELLULAR MATRIX; FEMALE; FRUIT; GENTIANAE MACROPHYLLAE; GLYCYRRHIZA; HUMAN; INTERVENTION STUDY; KNEE OSTEOARTHRITIS; MALE; MANCHURIAN WILDGINGER; MEDICINAL PLANT; MOLECULAR BIOLOGY; MORNING DOSAGE; PLANT ROOT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REHMANNIA; RHIZOME; SILERIS; SYNOVIAL FLUID; TAXILLUS; TREATMENT DURATION; TU CHUNG;

ASARUM; EUCOMMIA ULMOIDES; REHMANNIA; TAXILLUS;

EID: 52949152833     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41: 1343-1355
2. Zhang NZ, Shi QS, Zhang XZ, et al. Zhonghua Neike Zazhi 1995;34 (2): 84-87
3. Van Saase JL, van Romunde LK, Cats A, et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-280
4. Lawrence M. Indice of severity and disease activity for osteoarthritis. Semin Arthritis Rheum 1991;20(12):48
5. Murphy G, Knauper V, Atkinson S, et al. Matrix metalloproteinases in arthritic disease. Arthritis Res 2002;4(suppl 3):S39-49
6. Stanton H, Rogerson FM, East CJ, et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005;434: 648-652
7. Green DM, Noble PC, Bocell JR Jr, et al. Effect of early full weight-bearing after joint injury on inflammation and cartilage degradation. J Bone Joint Surg Am 2006; 88:2201-2209
8. Takahashi M, Naito K, Abe M, et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 2004;6:R208-R212
9. Gulotta LV, Hidaka C, Maher SA, et al. What's new in orthopaedic research. J Bone Joint Surg Am 2007;89(9):2092-2101
10. Massari L, Benazzo F, De Mattei M, et al. Effects of electrical physical stimuli on articular cartilage. J Bone Joint Surg Am 2007;89 Suppl 3:152-161
11. Monfort J, Tardif G, Reboul P, et al. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther 2006;8(1):R26
12. Klatt AR, Klinger G, Neumüller O, et al. TAK1 downregulation reduces IL-1beta induced expression of MMP13, MMP1 and TNF-alpha. Biomed Pharmacother 2006;60(2):55-61
13. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44(3):585-594
14. Iannone F, Lapadula G. The pathophysiology of osteoarthritis. Aging Clin Exp Res 2003;15(5):364-372
15. Mengshol JA, Vincenti MP, Brinckerhoff CE. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res 2001;29(21):4361-4372
16. Ahonen M, Poukkula M, Baker AH, et al. Tissue inhibitor of metalloproteinase-3 induces apoptosisin melanoma cells by stabilization of death receptors. Oncogene 2003;22:2121-2134
17. Wang HM, Yu DD, Tang TT, et al. Zhongguo Zhongyi Gushangke Zazhi 2007;7(15):45-49
18. Shao M, Niu W, Huang JW. Zhongyi Linchuang Kangfu 2006;19(10): 50-52
19. Zhao JT, Zhang QW, Fang B, et al. Zhongguo Shiyong Yiyao 2006;1(1):42-44
20. Alfano D, Franco P, Vocca I, et al. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb Haemost 2005;93(2): 205-211
21. Zhou QS, Zheng XH, Wang HB, et al. Zhongyiyao Tongbao 2007;8 (6): 50-54